Schwab Charles Investment Management Inc. held its stake in NanoString Technologies, Inc. (NASDAQ:NSTG) during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 24,100 shares of the biotechnology company’s stock at the end of the second quarter. Schwab Charles Investment Management Inc. owned 0.11% of NanoString Technologies worth $399,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. American International Group Inc. lifted its stake in NanoString Technologies by 7.4% during the first quarter. American International Group Inc. now owns 9,153 shares of the biotechnology company’s stock worth $182,000 after purchasing an additional 634 shares during the period. Bank of America Corp DE increased its holdings in shares of NanoString Technologies by 16.6% during the first quarter. Bank of America Corp DE now owns 11,404 shares of the biotechnology company’s stock worth $227,000 after buying an additional 1,627 shares in the last quarter. Strs Ohio increased its holdings in shares of NanoString Technologies by 22.7% during the second quarter. Strs Ohio now owns 40,000 shares of the biotechnology company’s stock worth $661,000 after buying an additional 7,400 shares in the last quarter. Bank of Montreal Can increased its holdings in shares of NanoString Technologies by 3,731.4% during the second quarter. Bank of Montreal Can now owns 9,387 shares of the biotechnology company’s stock worth $156,000 after buying an additional 9,142 shares in the last quarter. Finally, Vanguard Group Inc. increased its holdings in shares of NanoString Technologies by 2.7% during the first quarter. Vanguard Group Inc. now owns 588,558 shares of the biotechnology company’s stock worth $11,695,000 after buying an additional 15,343 shares in the last quarter. Hedge funds and other institutional investors own 93.04% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece of content was first published by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece of content can be accessed at https://www.watchlistnews.com/nanostring-technologies-inc-nstg-stake-held-by-schwab-charles-investment-management-inc/1684314.html.

Shares of NanoString Technologies, Inc. (NASDAQ:NSTG) opened at $8.32 on Tuesday. The company has a debt-to-equity ratio of 0.93, a quick ratio of 3.74 and a current ratio of 4.22. NanoString Technologies, Inc. has a fifty-two week low of $7.32 and a fifty-two week high of $23.45.

NanoString Technologies (NASDAQ:NSTG) last posted its quarterly earnings data on Thursday, November 2nd. The biotechnology company reported ($0.45) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.56) by $0.11. The company had revenue of $27.02 million during the quarter, compared to analyst estimates of $26.27 million. NanoString Technologies had a negative net margin of 44.24% and a negative return on equity of 227.21%. The company’s revenue was up 12.9% on a year-over-year basis. During the same quarter last year, the business posted ($0.51) earnings per share. equities analysts expect that NanoString Technologies, Inc. will post -2.26 earnings per share for the current fiscal year.

Several analysts have recently weighed in on NSTG shares. Zacks Investment Research lowered shares of NanoString Technologies from a “hold” rating to a “sell” rating in a report on Tuesday, October 17th. Cowen and Company reaffirmed a “buy” rating and set a $20.00 price objective on shares of NanoString Technologies in a report on Thursday, September 28th. Robert W. Baird dropped their price objective on shares of NanoString Technologies from $14.00 to $12.00 and set an “outperform” rating for the company in a report on Friday. Janney Montgomery Scott lowered shares of NanoString Technologies from a “buy” rating to a “neutral” rating in a report on Thursday, October 12th. Finally, BidaskClub lowered shares of NanoString Technologies from a “hold” rating to a “sell” rating in a report on Sunday, July 16th. Three investment analysts have rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $17.25.

About NanoString Technologies

NanoString Technologies, Inc develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample.

Institutional Ownership by Quarter for NanoString Technologies (NASDAQ:NSTG)

Receive News & Ratings for NanoString Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.